Results
1
-
3
of
3
MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping
,
Investigational New Drugs
[DOI: 10.1007/s10637-017-0545-x]
Kocienski, Philip, Synfacts 2014, 10, 668.
Synthesis of MET Kinase Inhibitor LY2801653
,
Synfacts
[DOI: 10.1055/s-0034-1378237]
Rossi, Renzo; Lessi, Marco; Manzini, Chiara; Marianetti, Giulia; Bellina, Fabio.
Direct (Hetero)arylation Reactions of (Hetero)arenes as Tools for the Step- and Atom-Economical Synthesis of Biologically Active Unnatural Compounds Including Pharmaceutical Targets
,
Synthesis 2016, 48, 3821-3862
[DOI: 10.1055/s-0036-1588303]